Prospective study to evaluate immunity to SARS-CoV2 in mothers with children in child-care facilities

Prospective study to evaluate immunity to SARS-CoV2 in mothers with children in child-care facilities - RoKiCo

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021614

Enrollment

400

Registered

2020-06-15

Start date

2020-04-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Mothers of children aged 1 to 10 years using a questionnaire

serology to asess specific SARS-CoV2 antibodies and SARS-CoV2 swab for PCR.

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: mothers of children aged 1 to 10 years, who visited child-care facilities. Place of residence: Rostock

Exclusion criteria

Exclusion criteria: missing informed consent

Design outcomes

Primary

Measure	Time frame
rate of SARS-CoV2 antibody prevalence	—

Secondary

Measure	Time frame
undetected COVID-19 infection	—

Countries

Germany

Contacts

Public ContactDagmar Michel-Lübs

Universitätsmedizin Rostock, KKS

kks@med.uni-rostock.de+493814947337

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026